FSE$SEOVF

Sernova Biotherapeutics Inc · Q3 2010 earnings

Q3 2010 earnings · · Investor relations

Headline financials

EPS (adj)

-€0.01

No prior period
Net Income

-€478K

No prior period
Operating Income

-€479K

No prior period
Gross Profit

€0.00

No prior period
R&D Expense

€38.6K

No prior period

Revenue & EPS history

Sernova Biotherapeutics Inc · Revenue · Quarterly

Historical earnings impact

How earnings announcements have historically affected this stock's price.

+2.5%

Avg return

Earnings day

Avg return

5 days after

Avg return

30 days after

19%

3 / 16 earnings

Positive

+27.4%

Q2 2012

Best reaction

-7.2%

Q2 2014

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2015+0.0%
Q4 2014+0.0%
Q3 2014+5.0%
Q2 2014-7.2%
Q4 2013+16.6%
Q3 2013+0.0%
Q2 2013+0.0%
Q4 2012-2.7%
Q3 2012+0.0%
Q2 2012+27.4%
Q4 2011+0.0%
Q3 2011+0.0%
Q2 2011+0.0%
Q4 2010+0.0%
Q3 2010+0.0%
Q2 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro